• Benguigui M*, Cooper TJ* , Kalkar P , Schif-Zuck S,  Halaban R, Bacchiocchi A, Kamer I, Deo A, Manobla B, Menachem R, Haj-Shomaly J, Vorontsova V, Raviv Z, Buxbaum B, Christopoulos P, Bar J, Lotem M, Sznol M, Ariel A, Shen-Orr S, Shaked Y. Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell. 2024 Feb 12;42(2):253-265.

  • Deo A, Sleeman J, Shaked Y. The role of host response to chemotherapy: resistance, metastasis and clinical implications. Clin Exp Metastasis. 2023 Nov 24: 10585-023-10243-5.
  • Vorontsova A., Cooper TJ., Haj-Shomaly J., Benguigui M., Levin S., Manobla B., Menachem R., Timaner M., Raviv Z., Shaked Y. Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene2023 Mar;42(10):771-781.

  • Udasin, R., Sil, A., Zomot, E., Achildiev Cohen, H., Haj, J., Engelmayer, N., Lev, S., Binshtok, AM., Shaked, Y., Kienzler, MA., and Palty, R. Photopharmacological modulation of native CRAC channels using azoboronate photoswitches. PNAS 2022 Mar 29;119(13).
  • Waldhom, I., Holland, R., Goshen-Lago, T., Benguigui, M., Halberthal, M., Shaked, Y., Ben-Aharon, I., Long-term immunogenicity of BNT162b2 vaccine in patents with solid tumors. JAMA Oncology, 2022;8(6):940-941.
  • Harel, M., Lahav, C., Jacob, E., Dahan, N., Sela, I., Elon, Y., Raveh Shoval S., Yahalom, G., Kamer, I., Zer, A., Sharon, O., Carbone, D., Dicker, A., Bar, J., and Shaked Y. Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade. Journal of immunotherapy of cancer
  • Benguigui, M., Vorontsova, A., Timaner, M., Levin, S., Haj-Shomaly, J., Deo, A., Menachem, R., Manobla, B., Cooper, TJ., Raviv, Z., Shaked, Y. Bv8 blockade sensitizes anti-PD1 therapy resistant tumors. Frontiers in immunology 07 July 2022.


Send us your detailed inquiry to

Pages: 1 2 3 4